Ustekinumab for the treatment of paradoxical skin reactions and cutaneous manifestations of inflammatory bowel diseases

Wu, JS; Smogorzewski, J

Smogorzewski, J (corresponding author), Harbor UCLA Med Ctr, 1000 W Carson St, Torrance, CA 90502 USA.

DERMATOLOGIC THERAPY, ; ():

Abstract

Ustekinumab (STELARA), a human monoclonal antibody directed against IL-12 and IL-23, is FDA-approved to treat psoriasis, psoriatic arthritis, Crohn's ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索